Parallel Bio

Business Services · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1000 Marina Blvd Ste 105, Brisbane, Cali...

Revenue

$5.9 Million

Industry

Business Services Research & Development

About Parallel Bio

Parallel Bio is pioneering human-first drug discovery by combining organoids and AI to create true-to-life models of human biology. The company developed the first platform that replicates the human immune system across diverse populations, predicting drug success and identifying disease targets with accuracy and speed far beyond the limits of traditional animal models. Pharmaceutical partners, including three Fortune 500 companies, are using its Clinical Trial in a Dish to test the safety and efficacy of immunotherapies. Based in Cambridge, Mass., Parallel Bio was founded in 2021 by two scientists behind the world's first scalable human immune organoid.Explore more
Parallel Bio's Social MediaSIC Code 87,873NAICS Code 54,541Show more

Parallel Bio Org Chart

PhoneEmail
AG
United States flag for contact location.

Head of Technology

PhoneEmail
JT
United States flag for contact location.

Head of Immunology

PhoneEmail
KK
United States flag for contact location.

Biology Director, Platform

PhoneEmail
AM
United States flag for contact location.

Director of Biobanking

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
AG
United States flag for contact location.

Senior Scientist

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Parallel Bio

Compare insights from companies similar to Parallel Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Parallel Bio

$5.9M
11-50
Private
$25.3M
2021
AG
Ari GesherHead of Technology
$5.2M
11-50
Private
$25M
2017
Martin Brenner, Chief Executive Officer & Scientific Chief & Officer at RubrYc Therapeutics
Martin BrennerCEO & Scientific Chief & Officer
<$5M
11-50
Private
-
2001
N/A
<$5M
11-50
Private
-
2004
<$5M
11-50
Private
-
2016
N/A
<$5M
1-10
Private
-
2016
N/A
<$5M
11-50
Private
-
2020
Illustration of an envelope

Parallel Bio Tech Stack

A closer look at the technologies used by Parallel Bio

Top Business Services Companies

Frequently Asked Questions Regarding Parallel Bio

What is Parallel Bio's official website?
Parallel Bio's official website is parallel.bio
What is Parallel Bio's Revenue?
Parallel Bio's revenue is $5.9 Million
What is Parallel Bio's SIC code?
Parallel Bio's SIC: 87,873
What is Parallel Bio's NAICS code?
Parallel Bio's NAICS: 54,541
How many employees does Parallel Bio have?
Parallel Bio has 11-50 employees
What industry does Parallel Bio belong to?
Parallel Bio is in the industry of: Business Services, Research & Development
What is Parallel Bio competition?
Parallel Bio top competitors include: ReviveMed, Helix BioStructures, Ensol Biosciences, FAR Biotech
What technology does Parallel Bio use?
Some of the popular technologies that Parallel Bio uses are: NS1, Google Cloud DNS, Squarespace Online Stores, Google Cloud Platform
What does Parallel Bio do?

Parallel Bio is pioneering human-first drug discovery by combining organoids and AI to create true-to-life models of human biology. The company developed the first platform that replicates the human immune system across diverse populations, predicting drug success and identifying disease targets with accuracy and speed far beyond the limits of trad... itional animal models. Pharmaceutical partners, including three Fortune 500 companies, are using its Clinical Trial in a Dish to test the safety and efficacy of immunotherapies. Based in Cambridge, Mass., Parallel Bio was founded in 2021 by two scientists behind the world's first scalable human immune organoid.Read More

What are Parallel Bio social media links?
Parallel Bio Linkedin page Parallel Bio Twitter page
Who invested in Parallel Bio?
Parallel Bio has 8 investors including Undeterred Capital, Y Combinator, Refactor Capital and Breakout Ventures.
Is Parallel Bio a public company?
Parallel Bio is private company therefore does not currently have an official ticker symbol
See more information about Parallel Bio

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.